Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway

Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway

Abstract Background New acute and preventive migraine medications are available, but data on current treatment patterns are limited. This study describes migraine treatment patterns among patients initiating novel acute migraine specific medications (nAMSMs), overall and by prior use of anti-calcito...

Full description

Bibliographic Details
Main Authors: Zifan Zhou, Robert Urman, Karminder Gill, Andrew S. Park, Fiston Vuvu, Leah B. Patel, Jingsong Lu, Rolin L. Wade, Lindsay Frerichs, Mark E. Bensink
Format: Article
Language:English
Published: BMC 2023-11-01
Series:The Journal of Headache and Pain
Subjects:
Acute migraine therapy
Prophylactic/preventive treatment
CGRP
Migraine
Online Access:https://doi.org/10.1186/s10194-023-01678-y

Internet

https://doi.org/10.1186/s10194-023-01678-y

Similar Items